Maprotiline hydrochloride - Generic Drug Details
What are the generic drug sources for maprotiline hydrochloride and what is the scope of patent protection?
Maprotiline hydrochloride
is the generic ingredient in two branded drugs marketed by Novartis, Am Therap, Heritage Pharma, Rising, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.Summary for maprotiline hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 5 |
| NDAs: | 11 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Clinical Trials: | 3 |
| Patent Applications: | 1,714 |
| What excipients (inactive ingredients) are in maprotiline hydrochloride? | maprotiline hydrochloride excipients list |
| DailyMed Link: | maprotiline hydrochloride at DailyMed |
Recent Clinical Trials for maprotiline hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Rochester | Phase 1 |
| Hannover Medical School | Phase 3 |
| VA Office of Research and Development | Phase 2 |
Medical Subject Heading (MeSH) Categories for maprotiline hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for maprotiline hydrochloride
US Patents and Regulatory Information for maprotiline hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | MAPROTILINE HYDROCHLORIDE | maprotiline hydrochloride | TABLET;ORAL | 072285-003 | Oct 3, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | MAPROTILINE HYDROCHLORIDE | maprotiline hydrochloride | TABLET;ORAL | 071943-001 | Dec 30, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | MAPROTILINE HYDROCHLORIDE | maprotiline hydrochloride | TABLET;ORAL | 072285-001 | Oct 3, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | MAPROTILINE HYDROCHLORIDE | maprotiline hydrochloride | TABLET;ORAL | 072285-002 | Oct 3, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
